Home > News > Can Medical Nanotechnology Shorten Clinical Trials and Regulatory Pathways?
September 13th, 2005
Can Medical Nanotechnology Shorten Clinical Trials and Regulatory Pathways?
Nanotechnology is poised to enable advances that could be utilized to shave time and expense from multiple stages of the drug discovery and development efforts.
Ohio State University
National Cancer Institute
GS7 Graphene Sensor maybe Solution in Fight Against Cancer January 25th, 2015
Nanotechnology in Energy Applications Market Research Report 2014-2018: Radiant Insights, Inc January 15th, 2015
'Mind the gap' between atomically thin materials December 23rd, 2014
A novel method for identifying the body’s ‘noisiest’ networks November 19th, 2014
Made-in-Singapore rapid test kit detects dengue antibodies from saliva: IBN's MedTech innovation simplifies diagnosis of infectious diseases January 29th, 2015
Iranian Researchers Planning to Produce Edible Insulin January 28th, 2015
Nanoparticles that deliver oligonucleotide drugs into cells described in Nucleic Acid Therapeutics January 28th, 2015
Nanoliposomes Help Efforts to Cure Bacterial Infections January 27th, 2015